Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Bayer Earns Top Score in 2022 Corporate Equality Index for Fifth Consecutive Year
From Bayer
Via Business Wire
News headline image
Bayer to Launch Project Carbonview, an Industry-First Digital Carbon Footprint Measurement Solution for Agriculture
From Bayer
Via Business Wire
News headline image
Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival (OS) in Patients with mHSPC
From Bayer
Via Business Wire
News headline image
Bayer Invests €100 million in Sustainable Health Products to Advance Company’s 2030 Sustainability Commitments
From Bayer
Via Business Wire
News headline image
Bayer Wins U.S. Chamber of Commerce Foundation’s Annual Citizens Award
From Bayer
Via Business Wire
News headline image
Bayer Presented New Analyses Investigating KERENDIA® (finerenone) on Cardiovascular Outcomes in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes
From Bayer
Via Business Wire
News headline image
Bayer, Microsoft Enter Into Strategic Partnership to Optimize and Advance Digital Capabilities for Food, Feed, Fuel, Fiber Value Chain
From Bayer
Via Business Wire
News headline image
Bayer Focuses on Farmers and Drives Innovation into 2022
From Bayer
Via Business Wire
News headline image
Effective January 1, 2022: Rodrigo Santos Named Member of the Board of Management, Bayer AG, and President of the Crop Science Division
From Bayer
Via Business Wire
News headline image
Bayer Presents New Subgroup Analysis of Prespecified Pooled Analysis of Phase III Studies for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without SGLT2i Use at Baseline
From Bayer
Via Business Wire
News headline image
Bayer Consumer Health Media Team Named AdExchanger Winner for Best In-House Media Operations
From Bayer
Via Business Wire
News headline image
Bayer and CHS Collaborate to Bring Carbon Program Access to More Farmers
From Bayer
Via Business Wire
News headline image
Bayer to present new analyses adding to the depth of knowledge on the cardiovascular and renal outcomes of KERENDIA® (finerenone)
From Bayer
Via Business Wire
News headline image
During Breast Cancer Awareness Month, Bayer Shines a Light on the Impact of Breast Density on Breast Cancer Risk
From Bayer
Via Business Wire
News headline image
Bayer fuels leading market positions in Crop Science through delivery of unmatched innovation
From Bayer
Via Business Wire
News headline image
Bayer Appoints New General Managers for Nutritionals and Digestive Health Businesses
From Bayer
Via Business Wire
News headline image
Updated Vitrakvi® (larotrectinib) Sub-Analysis at ATA 2021 Supports Efficacy and Safety in Adult and Pediatric TRK Fusion Thyroid Cancer Patients
From Bayer
Via Business Wire
News headline image
Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene
From Bayer
Via Business Wire
News headline image
Midol® by Bayer Receives Honorable Mention in Fast Company’s 2021 Innovation by Design Awards
From Bayer
Via Business Wire
News headline image
Bayer Hires Nicole Hayes as Director of U.S. External Communications
From Bayer
Via Business Wire
News headline image
On the 15th Anniversary of World Contraception Day Bayer Releases Survey Results that Highlight the Role of Contraceptives in Women’s Lives
From Bayer
Via Business Wire
News headline image
Bayer Extends Clinical Development Program for KERENDIA® (finerenone) With Phase III Study to Investigate Use in Patients With Nondiabetic Chronic Kidney Disease
From Bayer
Via Business Wire
News headline image
Latest Analyses of Vitrakvi® (larotrectinib) Support Consistently Meaningful Clinical Profile for Both Adult and Pediatric Patients with TRK Fusion Cancer
From Bayer
Via Business Wire
News headline image
NUBEQA® (darolutamide) Impact on Local Symptoms Evaluated in Men with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
From Bayer
Via Business Wire
News headline image
Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures
From Bayer
Via Business Wire
Tickers OTC
News headline image
Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards
From Bayer
Via Business Wire
News headline image
Bayer to Highlight Expanded Research from Growing Oncology Portfolio at ESMO Congress 2021
From Bayer
Via Business Wire
News headline image
Bayer and Luke Bryan Team Up Again for “Here’s to the Farmer” Campaign
From Bayer
Via Business Wire
News headline image
Bayer Starts Phase III Clinical Development Program OASIS With Investigational Product, Elinzanetant
From Bayer
Via Business Wire
News headline image
Bayer Announces KERENDIA® (finerenone) Reduces the Risk of Cardiovascular Outcomes in New Phase III FIGARO-DKD Study in Adults With Chronic Kidney Disease (Stages 1-4) Associated With Type 2 Diabetes
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.